BONRAYBIO CO., LTD.
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
1. LensHooke X3 PRO Semen Quality Analyzer
2. LensHooke X12 PRO Semen Analysis System
3. LensHooke X1 PRO Semen Quality Analyzer
2. LensHooke X12 PRO Semen Analysis System
3. LensHooke X1 PRO Semen Quality Analyzer
Founded Year
2016
Unified Business No.
42686138
Status
Active
Number of Employees
0
Total Paid-in
Capital
248,007,850 (NT$)
Location of Company
Taiwan
, Taichung City
Exit Status
Emerging Stock Exchange(2023)、Innovation Board(2024)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Bonraybio is a team formed by the engineers & scientist with more than 10 years' experience in medical instrument development field. We are dedicated to the development of high-precision and user-friendly medical instrument and solution to assist to improve the medical quality around the world.
Recently, the aging population and the increasing number of infertility have led to problems in social, economic, and many other aspects. The population is a basic index to evaluate the competitive strength of a country. Therefore, to increase the fertility rate has become one of the important issues for most of the countries. However, most of companies are all dedicated on female factor, the research or solution of male factor are quite limited.
Therefore, we create the LensHooke. From 2016, LensHooke has developed and introduced its basic semen analysis, advanced sperm DNA Fragmentation and also the sperm separation solutions to the market successfully.
Recently, the aging population and the increasing number of infertility have led to problems in social, economic, and many other aspects. The population is a basic index to evaluate the competitive strength of a country. Therefore, to increase the fertility rate has become one of the important issues for most of the countries. However, most of companies are all dedicated on female factor, the research or solution of male factor are quite limited.
Therefore, we create the LensHooke. From 2016, LensHooke has developed and introduced its basic semen analysis, advanced sperm DNA Fragmentation and also the sperm separation solutions to the market successfully.
